domstat.net
oncologyeducation.ca
MENU
last data update: 1969/12/31, 16:00
Website loading time
during the test: 5.63 s
cable connection (average): 6.04 s
DSL connection (average): 6.45 s
modem (average): 28.25 s
HTTP headers
HTTP/1.1 200 OK
Date: Sat, 15 Oct 2011 07:57:14 GMT
Server: Apache/2.2.3 (CentOS)
X-Powered-By: PHP/5.2.5
Set-Cookie: PHPSESSID=79kr9divkn8uh4243t86nghh23; expires=Sat, 22 Oct 2011 07:57:15 GMT; path=/
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Vary: Accept-Encoding
Connection: close
Content-Type: text/html; charset=UTF-8
Information about DNS servers
| oncologyeducation.ca | A | 72.47.233.42 | IN | 43200 | |
| oncologyeducation.ca | SOA | ns.oncologyeducation.ca | sean.bigblock.ca | 1310140250 | 10800 3600 604800 10800 IN 43200 |
| oncologyeducation.ca | TXT | google-site-verification=38cYinalwdbJl_qUV5XTmLtQt32zEmQNnHfUTdIoeiA | Array | IN | 43200 |
| oncologyeducation.ca | TXT | google-site-verification=cVgZlbInUaqM5MSL5FdoQEYCC5jlTtl_CkA8Gm4CnoA | Array | IN | 43200 |
| oncologyeducation.ca | MX | 50 | ASPMX3.GOOGLEMAIL.COM | IN | 43200 |
| oncologyeducation.ca | MX | 10 | ASPMX.L.GOOGLE.COM | IN | 43200 |
| oncologyeducation.ca | MX | 20 | ALT1.ASPMX.L.GOOGLE.COM | IN | 43200 |
| oncologyeducation.ca | MX | 30 | ALT2.ASPMX.L.GOOGLE.COM | IN | 43200 |
| oncologyeducation.ca | MX | 40 | ASPMX2.GOOGLEMAIL.COM | IN | 43200 |
| oncologyeducation.ca | NS | ns.oncologyeducation.ca | IN | 43200 |
Received from the first DNS server
Request to the server "oncologyeducation.ca"
You used the following DNS server:
DNS Name: ns.oncologyeducation.ca
DNS Server Address: 72.47.233.42#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 36668
flag: qr aa rd REQUEST: 1, ANSWER: 10, AUTHORITY: 0, ADDITIONAL: 1
REQUEST SECTION:
oncologyeducation.ca. IN ANY
ANSWER SECTION:
oncologyeducation.ca. 86400 IN MX 40 ASPMX2.GOOGLEMAIL.COM.
oncologyeducation.ca. 86400 IN MX 50 ASPMX3.GOOGLEMAIL.COM.
oncologyeducation.ca. 86400 IN MX 10 ASPMX.L.GOOGLE.COM.
oncologyeducation.ca. 86400 IN MX 20 ALT1.ASPMX.L.GOOGLE.COM.
oncologyeducation.ca. 86400 IN MX 30 ALT2.ASPMX.L.GOOGLE.COM.
oncologyeducation.ca. 86400 IN TXT "google-site-verification=38cYinalwdbJl_qUV5XTmLtQt32zEmQNnHfUTdIoeiA"
oncologyeducation.ca. 86400 IN TXT "google-site-verification=cVgZlbInUaqM5MSL5FdoQEYCC5jlTtl_CkA8Gm4CnoA"
oncologyeducation.ca. 86400 IN SOA ns.oncologyeducation.ca. sean.bigblock.ca. 1310140250 10800 3600 604800 10800
oncologyeducation.ca. 86400 IN NS ns.oncologyeducation.ca.
oncologyeducation.ca. 86400 IN A 72.47.233.42
SECTION NOTES:
ns.oncologyeducation.ca. 86400 IN A 72.47.233.42
Received 432 bytes from address 72.47.233.42#53 in 73 ms
Received from the second DNS server
Subdomains (the first 50)
Typos (misspells)
| incologyeducation.ca kncologyeducation.ca lncologyeducation.ca pncologyeducation.ca 0ncologyeducation.ca 9ncologyeducation.ca obcologyeducation.ca omcologyeducation.ca ojcologyeducation.ca ohcologyeducation.ca onxologyeducation.ca onvologyeducation.ca onfologyeducation.ca ondologyeducation.ca oncilogyeducation.ca oncklogyeducation.ca oncllogyeducation.ca oncplogyeducation.ca onc0logyeducation.ca onc9logyeducation.ca oncokogyeducation.ca oncopogyeducation.ca oncooogyeducation.ca oncoligyeducation.ca oncolkgyeducation.ca oncollgyeducation.ca oncolpgyeducation.ca oncol0gyeducation.ca oncol9gyeducation.ca oncolofyeducation.ca oncolovyeducation.ca oncolobyeducation.ca oncolohyeducation.ca oncoloyyeducation.ca oncolotyeducation.ca oncologteducation.ca oncologgeducation.ca oncologheducation.ca oncologueducation.ca oncolog7education.ca oncolog6education.ca oncologywducation.ca oncologysducation.ca oncologydducation.ca oncologyrducation.ca oncology4ducation.ca oncology3ducation.ca | oncologyesucation.ca oncologyexucation.ca oncologyecucation.ca oncologyefucation.ca oncologyerucation.ca oncologyeeucation.ca oncologyedycation.ca oncologyedhcation.ca oncologyedjcation.ca oncologyedication.ca oncologyed8cation.ca oncologyed7cation.ca oncologyeduxation.ca oncologyeduvation.ca oncologyedufation.ca oncologyedudation.ca oncologyeducztion.ca oncologyeducstion.ca oncologyeducwtion.ca oncologyeducqtion.ca oncologyeducarion.ca oncologyeducafion.ca oncologyeducagion.ca oncologyeducayion.ca oncologyeduca6ion.ca oncologyeduca5ion.ca oncologyeducatuon.ca oncologyeducatjon.ca oncologyeducatkon.ca oncologyeducatoon.ca oncologyeducat9on.ca oncologyeducat8on.ca oncologyeducatiin.ca oncologyeducatikn.ca oncologyeducatiln.ca oncologyeducatipn.ca oncologyeducati0n.ca oncologyeducati9n.ca oncologyeducatiob.ca oncologyeducatiom.ca oncologyeducatioj.ca oncologyeducatioh.ca ncologyeducation.ca ocologyeducation.ca onologyeducation.ca onclogyeducation.ca oncoogyeducation.ca | oncolgyeducation.ca oncoloyeducation.ca oncologeducation.ca oncologyducation.ca oncologyeucation.ca oncologyedcation.ca oncologyeduation.ca oncologyeduction.ca oncologyeducaion.ca oncologyeducaton.ca oncologyeducatin.ca oncologyeducatio.ca nocologyeducation.ca ocnologyeducation.ca onoclogyeducation.ca oncloogyeducation.ca oncoolgyeducation.ca oncolgoyeducation.ca oncoloygeducation.ca oncologeyducation.ca oncologydeucation.ca oncologyeudcation.ca oncologyedcuation.ca oncologyeduaction.ca oncologyeductaion.ca oncologyeducaiton.ca oncologyeducatoin.ca oncologyeducatino.ca ooncologyeducation.ca onncologyeducation.ca onccologyeducation.ca oncoologyeducation.ca oncollogyeducation.ca oncoloogyeducation.ca oncologgyeducation.ca oncologyyeducation.ca oncologyeeducation.ca oncologyedducation.ca oncologyeduucation.ca oncologyeduccation.ca oncologyeducaation.ca oncologyeducattion.ca oncologyeducatiion.ca oncologyeducatioon.ca oncologyeducationn.ca |
Location
IP: 72.47.233.42
continent: NA, country: United States (USA), city: Culver City
Website value
rank in the traffic statistics:
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 158.35 KB
text per all code ratio: 29 %
title: OncologyEducation.com | Home
description: An online resource providing oncology updates, key journal articles, conference information, CME events, and links to clinical resources to the busy oncologist.
keywords: oncology, cancer, updates, medical oncology, lung cancer, breast cancer, gi cancer, gu cancer, hematology, CME, practice guidelines, palliative care, tumour sites, Canadian
encoding: UTF-8
language: en
Website code analysis
one word phrases repeated minimum three times
two word phrases repeated minimum three times
three word phrases repeated minimum three times
B tags
U tags
I tags
images
| file name | alternative text |
|---|---|
| transparent.gif | |
| HONConduct215559_s2.gif | This website is certified by Health On the Net Foundation. Click to verify. |
headers
H1
H2
2011 ECCO-ESMO Multidisciplinary Cancer Congress
Welcome to the New OncologyEducation.com Website
2011 Best of Oncology Conference
AJCC Online Handbook
The Latest ECCO-ESMO 2011 Updates
Clinical Trial Endpoints in Breast Cancer Video
Dr. Alan Lipton Presentation - Update on Mangement of Bone Metastases
Best of Lung Cancer - ASCO 2011 - Video Highlights
Metastatic Melanoma: Novel Therapies - Video
New Educational Content
Recent Updates
Networking
Information
Conferences
Residents
In The Clinic
COMET
H3
2011 ECCO-ESMO Multidisciplinary Cancer Congress
Welcome to the New OncologyEducation.com Website
2011 Best of Oncology Conference
AJCC Online Handbook
The Latest ECCO-ESMO 2011 Updates
Clinical Trial Endpoints in Breast Cancer Video
Dr. Alan Lipton Presentation - Update on Mangement of Bone Metastases
Best of Lung Cancer - ASCO 2011 - Video Highlights
Metastatic Melanoma: Novel Therapies - Video
New Educational Content
Recent Updates
Networking
Information
Conferences
Residents
In The Clinic
COMET
H4
H5
December 2009
September 2009 ECCO
Slide Kits/Presentations
Treatment Summaries / Practice Guidelines
COMET
Autumn Internal Medicine Update in Oncology 2011
Lymphoma & Myeloma 2011
3rd Annual Atlantic Canada Thoracic Oncology Conference
Toronto Cancer - 2011
Canadian Association of General Practitioners in Oncology
H6
internal links
| address | anchor text |
|---|---|
| utility-pages/login-register/register.html | |
| utility-pages/login-register/log-in.html | |
| / | img |
| networking/ | Networking |
| networking/graduate-programs/ | Graduate Programs |
| networking/graduate-programs/education/ | Education |
| networking/graduate-programs/research/ | Research |
| networking/cancer-centres-and-societies/ | Cancer Centres and Societies |
| networking/cancer-centres-and-societies/cancer-centers/ | Cancer Centers |
| networking/cancer-centres-and-societies/cancer-centers/canada.html | Canada |
| networking/cancer-centres-and-societies/cancer-centers/united-states.html | United States |
| networking/cancer-centres-and-societies/cancer-centers/international.html | International |
| networking/cancer-centres-and-societies/cancer-societies-and-associations.html | Cancer Societies and Associations |
| networking/cancer-centres-and-societies/other-links.html | Other Links |
| networking/job-postings/ | Job Postings |
| networking/job-postings/alberta.html | Alberta |
| networking/job-postings/british-columbia.html | British Columbia |
| networking/job-postings/ontario.html | Ontario |
| networking/job-postings/saskatchewan.html | Saskatchewan |
| networking/job-postings/prince-edward-island.html | Prince Edward Island |
| networking/oncology-groups/ | Oncology Groups |
| networking/oncology-groups/comet.html | COMET |
| information/ | Information |
| information/breast/ | Breast |
| information/breast/latest-oncology-updates/ | Latest Oncology Updates |
| information/breast/latest-oncology-updates/june-2010.html | June 2010 ASCO |
| information/breast/latest-oncology-updates/april-2010.html | April 2010 EBCC |
| information/breast/key-journal-articles/ | Key Journal Articles |
| information/breast/key-journal-articles/prevention.html | Prevention |
| information/breast/key-journal-articles/screening.html | Screening |
| information/breast/key-journal-articles/pregnancy.html | Pregnancy |
| information/breast/key-journal-articles/metastatic-chemo.html | Metastatic Chemo |
| information/breast/key-journal-articles/adjuvant-chemo.html | Adjuvant Chemo |
| information/breast/key-journal-articles/neoadjuvant/ | Neoadjuvant |
| information/breast/key-journal-articles/bisphosphonates.html | Bisphosphonates |
| information/breast/key-journal-articles/targeted-agents.html | Targeted Agents |
| information/breast/key-journal-articles/surgery.html | Surgery |
| information/breast/key-journal-articles/dcis.html | DCIS |
| information/breast/key-journal-articles/endocrine.html | Endocrine |
| information/breast/key-journal-articles/genetics.html | Genetics |
| information/breast/key-journal-articles/follow-up.html | Follow Up |
| information/breast/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/lung/ | Lung |
| information/lung/latest-oncology-updates/ | Latest Oncology Updates |
| information/lung/latest-oncology-updates/june-2011.html | June 2011 ASCO |
| information/lung/latest-oncology-updates/june-2010.html | June 2010 ASCO |
| information/lung/latest-oncology-updates/may-2010.html | May 2010 IPASS |
| information/lung/key-journal-articles/ | Key Journal Articles |
| information/lung/key-journal-articles/early-stage.html | Early Stage |
| information/lung/key-journal-articles/metastatic-chemo/ | Metastatic Chemo |
| information/lung/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/gi-updates/ | GI |
| information/gi-updates/latest-oncology-updates/ | Latest Oncology Updates |
| information/gi-updates/latest-oncology-updates/july-2011.html | July 2011 ACOG |
| information/gi-updates/latest-oncology-updates/june-2011.html | June 2011 ASCO |
| information/gi-updates/latest-oncology-updates/november-2010.html | November 2010 ESMO |
| information/gi-updates/latest-oncology-updates/june-2010.html | June 2010 ASCO |
| information/gi-updates/key-journal-articles/ | Key Journal Articles |
| information/gi-updates/key-journal-articles/adjuvant/ | Colorectal - Adjuvant |
| information/gi-updates/key-journal-articles/adjuvant/colon-adjuvant.html | Colon |
| information/gi-updates/key-journal-articles/adjuvant/rectal.html | Rectal |
| information/gi-updates/key-journal-articles/metastatic.html | Colorectal - Metastatic |
| information/gi-updates/key-journal-articles/metastatic/chemotherapy/ | Chemotherapy |
| information/gi-updates/key-journal-articles/metastatic/egfr/ | EGFR |
| information/gi-updates/key-journal-articles/gastric.html | Gastric |
| information/gi-updates/key-journal-articles/pancreatic-adjuvant.html | Pancreatic - Adjuvant |
| information/gi-updates/key-journal-articles/pancreatic-metastatic.html | Pancreatic - Metastatic |
| information/gi-updates/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/gi-updates/slidekits-presentations.html | Slide Kits/Presentations |
| information/gu-updates/ | GU |
| information/gu-updates/latest-oncology-updates/ | Latest Oncology Updates |
| information/gu-updates/latest-oncology-updates/june-2011.html | June 2011 ASCO |
| information/gu-updates/latest-oncology-updates/october-2010.html | October 2010 ESMO |
| information/gu-updates/latest-oncology-updates/july-2010.html | July 2010 |
| information/gu-updates/latest-oncology-updates/june-2010.html | June 2010 ASCO |
| information/gu-updates/follow-up/ | Guidelines |
| information/gu-updates/key-journal-articles/ | Key Journal Articles |
| information/gu-updates/key-journal-articles/germ-cell/ | Germ Cell |
| information/gu-updates/key-journal-articles/germ-cell/stage-i-nsgct.html | Stage I NSGCT |
| information/gu-updates/key-journal-articles/germ-cell/metastatic.html | Metastatic |
| information/gu-updates/key-journal-articles/germ-cell/post-chemotherapy-surgery.html | Post Chemotherapy Surgery |
| information/gu-updates/key-journal-articles/germ-cell/relapsed-gct.html | Relapsed GCT |
| information/gu-updates/key-journal-articles/germ-cell/pet-scan-imaging.html | PET Scan Imaging |
| information/gu-updates/key-journal-articles/renal-cell/ | Renal Cell |
| information/gu-updates/key-journal-articles/renal-cell/targeted-therapy.html | Targeted Therapy |
| information/gu-updates/key-journal-articles/renal-cell/bisphosphonates.html | Bisphosphonates |
| information/gu-updates/key-journal-articles/renal-cell/role-of-nephrectomy.html | Role of Nephrectomy |
| information/gu-updates/key-journal-articles/renal-cell/immunotherapy.html | Immunotherapy |
| information/gu-updates/key-journal-articles/bladder/ | Bladder |
| information/gu-updates/key-journal-articles/prostate/ | Prostate |
| information/gu-updates/key-journal-articles/prostate/bone-targeted-therapies.html | Bone Targeted Therapies |
| information/gu-updates/key-journal-articles/prostate/chemotherapy.html | Chemotherapy |
| information/gu-updates/key-journal-articles/prostate/immunotherapy.html | Immunotherapy |
| information/gu-updates/key-journal-articles/prostate/secondary-hormonal-manipulation.html | Secondary Hormonal Manipulation |
| information/gu-updates/key-journal-articles/prostate/systemic-therapy-post-docetaxel-in-a-metastatic-setting.html | Systemic Therapy post Docetaxel in a Metastatic Setting |
| information/gu-updates/key-journal-articles/prostate/other.html | Other |
| information/gu-updates/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/head-and-neck/ | Head & Neck |
| information/head-and-neck/latest-oncology-updates/ | Latest Oncology Updates |
| information/head-and-neck/latest-oncology-updates/june-2011.html | June 2011 ASCO |
| information/head-and-neck/key-journal-articles/ | Key Journal Articles |
| information/hematology/ | Hematology |
| information/hematology/latest-oncology-updates/ | Latest Oncology Updates |
| information/hematology/latest-oncology-updates/july-2010.html | July 2010 ASCO & EHA |
| information/hematology/latest-oncology-updates/january-2009.html | January 2009 ASH |
| information/hematology/continuing-medical-education-activities/ | Continuing Medical Education Activities |
| information/hematology/continuing-medical-education-activities/international-speaker-series-hematology-conference.html | International Speaker Series: Hematology Conference |
| information/hematology/continuing-medical-education-activities/international-speaker-series-leukemia.html | International Speaker Series: Leukemia |
| information/hematology/continuing-medical-education-activities/international-speaker-series-lymphoma.html | International Speaker Series: Lymphoma |
| information/palliative-care/ | Palliative Care |
| information/other-tumor-sites/ | Other Tumor Sites |
| information/other-tumor-sites/slide-kits-and-presentations/ | Slide Kits & Presentations |
| information/other-tumor-sites/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/supportive-care/ | Supportive Care |
| information/supportive-care/hot-spot-newsletter.html | Hot Spot Newsletter |
| information/supportive-care/july-2011.html | July 2011 |
| information/supportive-care/patient-care.html | Patient Care |
| information/teaching-cases/ | Teaching Cases |
| conferences/ | Conferences |
| conferences/oncology-conferences.html | Oncology Conferences |
| conferences/cme-events.html | CME Events |
| conferences/events-calendar.html | Events Calendar |
| in-the-clinic/ | In The Clinic |
| in-the-clinic/treatment-summaries-practice-guidelines.html | Treatment Summaries / Practice Guidelines |
| in-the-clinic/decision-aids.html | Decision Aids |
| in-the-clinic/drug-information.html | Drug Information |
| in-the-clinic/clinical-trials.html | Clinical Trials |
| multimedia/ | Multimedia |
| contact-us/ | Contact |
| contact-us/site-map.html | Site Map |
| oncology-education-site-information/rss.rss | rss-feed |
| .html | |
| the-latest-ecco-esmo-2011-updates/ | more info... |
| mailto:info@oncologyeducation.com | info@oncologyeducation.com |
| http://oncologyeducation.ca/ | |
| in-the-clinic/decision-aids/staging-tools.html | more info... |
| information/gi-updates/key-journal-articles/metastatic/egfr/egfr-2011.html | Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial - (1 day, 6 hours ago) |
| information/gu-updates/key-journal-articles/prostate/other.html | Other - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/other/prostate-2007.html | Prostate-Specific Antigen and Pain Surrogacy Analysis in Metastatic Hormone-Refractory Prostate Cancer - Article Review by Dr Lori Wood - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/systemic-therapy-post-docetaxel-in-a-metastatic-setting/prostate-2010-(1).html | Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomized open-label trial Read a review of this article by Dr. Lori Wood - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/systemic-therapy-post-docetaxel-in-a-metastatic-setting/prostate-2011-(4).html | Abiraterone and Increased Survival in Metastatic Prostate Cancer Read a review of this article by Dr. Lori Wood - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/systemic-therapy-post-docetaxel-in-a-metastatic-setting.html | Systemic Therapy post Docetaxel in a Metastatic Setting - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/secondary-hormonal-manipulation/prostate-2004-(3).html | Antiandrogen Withdrawal Alone or in Combination with Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583) - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/secondary-hormonal-manipulation/flutamide-versus-prednisone.html | Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European Organization for Research and Treatment of Cancer Genitourinary Group - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/secondary-hormonal-manipulation.html | Secondary Hormonal Manipulation - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/immunotherapy/prostate-2010.html | Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/immunotherapy.html | Immunotherapy - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/chemotherapy/prostate-1996.html | Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/chemotherapy/prostate-2004-(2).html | Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/chemotherapy/prostate-2004-(1).html | Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer - (1 day, 13 hours ago) |
| information/gu-updates/key-journal-articles/prostate/chemotherapy/prostate-2007.html | Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared with Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report from the ASCENT Investigators - (1 day, 13 hours ago) |
| the-latest-ecco-esmo-2011-updates/ | The Latest ECCO-ESMO 2011 Updates |
| the-latest-ecco-esmo-2011-updates/ | [more] |
| multimedia/breast/breast-video/vx110144-01-drverma-endpoints-640-june15-1.flv.html | Clinical Trial Endpoints in Breast Cancer Video |
| multimedia/breast/breast-video/vx110144-01-drverma-endpoints-640-june15-1.flv.html | [more] |
| multimedia/general/video/dr-lipton-talk.html | Dr. Alan Lipton Presentation - Update on Mangement of Bone Metastases |
| multimedia/general/video/dr-lipton-talk.html | [more] |
| multimedia/lung/lung-cancer-video/best-of-lung-cancer-asco-2011-video-highlights.html | Best of Lung Cancer - ASCO 2011 - Video Highlights |
| multimedia/lung/lung-cancer-video/best-of-lung-cancer-asco-2011-video-highlights.html | [more] |
| multimedia/melanoma/video/spotlightonmelanoma-asco-2011.html | Metastatic Melanoma: Novel Therapies - Video |
| multimedia/melanoma/video/spotlightonmelanoma-asco-2011.html | [more] |
| information/teaching-cases/ | Teaching Cases |
| information/teaching-cases/ | [more] |
| information/breast/continuing-medical-education-activities.html | Continuing Medical Education Activities |
| information/breast/continuing-medical-education-activities.html | [more] |
| information/hematology/continuing-medical-education-activities/international-speaker-series-hematology-conference.html | International Speaker Series: Hematology Conference |
| information/hematology/continuing-medical-education-activities/international-speaker-series-hematology-conference.html | [more] |
| in-the-clinic/clinical-trials.html | Clinical Trials |
| in-the-clinic/clinical-trials.html | [more] |
| networking/job-postings/prince-edward-island.html | Job Postings - Prince Edward Island |
| networking/job-postings/prince-edward-island.html | [more] |
| the-latest-asco-2011-updates/world-lung-postcards.html | World Lung Postcards |
| the-latest-asco-2011-updates/world-lung-postcards.html | [more] |
| information/gu-updates/key-journal-articles/prostate/ | Key GU Journal Articles - Prostate |
| information/gu-updates/key-journal-articles/prostate/ | [more] |
| information/gi-updates/key-journal-articles/adjuvant/ | Key GI Journal Articles - Colorectal - Adjuvant |
| information/gi-updates/key-journal-articles/adjuvant/ | [more] |
| information/lung/key-journal-articles/metastatic-chemo/ | Key Lung Journal Articles - Metastatic |
| information/lung/key-journal-articles/metastatic-chemo/ | [more] |
| utility-pages/search-tools/search-advanced.html | Advanced Search |
| #tab-viewed | Most Viewed |
| #tab-events | Upcoming Events |
| #tab-twitter | |
| information/gu-updates/latest-oncology-updates/older-conference-updates/december-2009.html | December 2009 |
| information/breast/latest-oncology-updates/october-2010-esmo/september-2009.html | September 2009 ECCO |
| information/gi-updates/slidekits-presentations.html | Slide Kits/Presentations |
| in-the-clinic/treatment-summaries-practice-guidelines.html | Treatment Summaries / Practice Guidelines |
| networking/oncology-groups/comet.html | COMET |
| oncology-education-site-information/help-us-grow.html | Learn more about contributing to our website. |
| networking/graduate-programs/ | Graduate Programs |
| networking/canadian-medical-oncology-training-programs.html | Canadian Medical Oncology Training Programs |
| networking/research/ | Research |
| networking/cancer-centres-and-societies/ | Cancer Centres and Societies |
| networking/job-postings/ | Job Postings |
| networking/oncology-groups/ | Oncology Groups |
| information/breast/ | Breast |
| information/lung/ | Lung |
| information/gi-updates/ | GI Updates |
| information/gu-updates/ | GU Updates |
| information/head-and-neck/ | Head & Neck |
| information/hematology/ | Hematology |
| information/palliative-care/ | Palliative Care |
| information/other-tumor-sites/ | Other Tumor Sites |
| information/supportive-care/ | Supportive Care |
| information/teaching-cases/ | Teaching Cases |
| conferences/oncology-conferences.html | Oncology Conferences |
| conferences/cme-events.html | CME Events |
| conferences/events-calendar.html | Events Calendar |
| conferences/past-conferences.html | Past Conferences |
| residents/awards.html | Awards |
| residents/fellowships/ | Fellowships |
| residents/resident-links/ | Resident Links |
| in-the-clinic/treatment-summaries-practice-guidelines.html | Treatment Summaries / Practice Guidelines |
| in-the-clinic/decision-aids.html | Decision Aids |
| in-the-clinic/drug-information.html | Drug Information |
| in-the-clinic/clinical-trials.html | Clinical Trials |
| networking/oncology-groups/comet.html | COMET |
| oncology-education-site-information/about-us.html | About Us |
| contact-us/site-map.html | Site Map |
| oncology-education-site-information/acknowledgements.html | Acknowledgements |
| oncology-education-site-information/legal-disclaimer.html | Legal Disclaimer |
| oncology-education-site-information/privacy-policy.html | Privacy Policy |
| oncology-education-site-information/terms-and-conditions.html | Terms and Conditions |
external links
| address | anchor text |
|---|---|
| http://oncologyeducation.com/ | Home |
| http://jnci.oxfordjournals.org/content/97/22/1652.short | Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study |
| http://jnci.oxfordjournals.org/cgi/content/abstract/90/18/1371?maxtoshow= | Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study |
| http://www.nejm.org/doi/full/10.1056/NEJMoa065447?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=356&volume=356&firstpage=1295&firstpage=1295 | MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer |
| http://www.obmri.com/NEJN2007Mar29Editorial.pdf | The Evolving Role of MRI in the Detection and Evaluation of Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/nejmcp021804 | Mammographic Screening for Breast Cancer |
| http://jco.ascopubs.org/content/19/6/1671.abstract | Effect of Pregnancy on Overall Survival After the Diagnosis of Early-Stage Breast Cancer |
| http://jco.ascopubs.org/content/17/3/855.abstract | Management of Breast Cancer During Pregnancy Using a Standardized Protocol |
| http://theoncologist.alphamedpress.org/content/12/7/785.full | First-line Treatment Options for Patients with HER-2 Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy |
| http://theoncologist.alphamedpress.org/content/10/suppl_3/20.full | Extending Survival with Chemotherapy in Metastatic Breast Cancer |
| http://www.nature.com/bjc/journal/v93/n3/abs/6602680a.html | A systematic review of taxane-containing regimens for metastatic breast cancer |
| http://jco.ascopubs.org/cgi/content/abstract/21/4/588 | Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193) |
| http://jco.ascopubs.org/content/20/12/2812.abstract | Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results |
| http://jco.ascopubs.org/content/early/2011/09/11/JCO.2010.28.5437.short?rss=1 | Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960740-6/fulltext | Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open label, phase III, randomised controlled trial |
| http://jco.ascopubs.org/content/26/5/778.abstract | Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 |
| http://annonc.oxfordjournals.org/content/18/7/1133.full | Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 |
| http://www.nejm.org/doi/full/10.1056/NEJMoa071167 | Her2 and Response to Paclitaxel in Node Positive Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMra065241 | Current Concepts: Local Therapy and Survival in Breast Cancer |
| http://annonc.oxfordjournals.org/content/17/suppl_10/x59.full.pdf | Meta-analysis of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview |
| http://jco.ascopubs.org/content/24/36/5664.abstract | Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial |
| http://jco.ascopubs.org/content/24/23/3726.abstract | Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa054504?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=354&volume=354&firstpage=2103&firstpage=2103 | HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy |
| http://jama.ama-assn.org/content/295/14/1658.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=295&firstpage=1658&resourcetype=HWCIT | Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer |
| http://www.asco.org/ASCOv2/Education+%26+Training/Educational+Book?&vmview=edbk_detail_view&confID=40&abstractID=286 | Adjuvant Therapy for Breast Cancer in Older Women |
| http://www.asco.org/ASCOv2/Education+%26+Training/Educational+Book?&vmview=edbk_detail_view&confID=40&abstractID=49 | Adjuvant Chemotherapy for Patients With Estrogen Receptor--Positive Breast Cancer |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470204505704241/abstract | Selection of Adjuvant Chemotherapy for Treatment of Node-positive Breast Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673605665440/abstract | Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials |
| http://jama.ama-assn.org/content/293/9/1073.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=293&firstpage=1073&resourcetype=HWCIT | Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa041588?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=351&volume=351&firstpage=2817&firstpage=2817 | A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer |
| http://www.ncbi.nlm.nih.gov/pubmed/9713266 | Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI |
| http://jco.ascopubs.org/content/15/7/2483.short | Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 |
| http://jco.ascopubs.org/content/15/5/1858.abstract | Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22 |
| http://www.nejm.org/doi/full/10.1056/NEJM199504063321401 | Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up |
| http://jnci.oxfordjournals.org/content/early/2011/09/29/jnci.djr393.abstract | Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group |
| http://www.springerlink.com/content/pq1714701775h289/?p=9eaf744dba5c4a18a2c7fed9aaa5d771&pi=7 | A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer |
| http://www.ncbi.nlm.nih.gov/pubmed/19561507 | New results from the use of bisphosphonates in cancer patients |
| http://www.springerlink.com/content/7m406p6875453tj6/ | Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 |
| http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/69/2_MeetingAbstracts/31?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Gianni%2C+L&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT | Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: primary efficacy analysis of the NOAH trial |
| http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/69/2_MeetingAbstracts/5101?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=winter%2C+m.c.&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT | The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer |
| http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/69/2_MeetingAbstracts/31?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Gianni%2C+L&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT | Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 |
| http://meeting.ascopubs.org/cgi/content/abstract/25/18_suppl/532 | Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH): Antitumour and safety analysis |
| hhttp://onlinelibrary.wiley.com/doi/10.1002/cncr.22789/abstract | Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer |
| http://www.cancertreatmentreviews.com/article/S0305-7372(06)00204-0/abstract | Neoadjuvant endocrine therapy in breast cancer |
| http://jco.ascopubs.org/content/24/13/2019.abstract | Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 |
| http://jco.ascopubs.org/content/24/12/1940.abstract | Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Updat |
| http://jco.ascopubs.org/content/23/25/5983.abstract | Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks |
| http://jco.ascopubs.org/content/23/22/5108.full | Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial |
| http://jco.ascopubs.org/content/23/16/3676.short | Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer |
| http://www.journals.elsevierhealth.com/periodicals/yctrv/article/PIIS0305737204001513/abstract | Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution? |
| http://jnci.oxfordjournals.org/content/97/3/188.short | Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis |
| http://jco.ascopubs.org/content/21/22/4165.abstract | The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 |
| http://jco.ascopubs.org/content/21/22/4165.abstract | Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel |
| http://jco.ascopubs.org/content/21/22/4165.abstract | Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902 |
| http://annonc.oxfordjournals.org/content/12/11/1527.abstract | Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study |
| http://jco.ascopubs.org/content/16/8/2672.short | Effect of preoperative chemotherapy on the outcome of women with operable breast cancer |
| http://jco.ascopubs.org/content/20/15/3219.abstract | Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer |
| http://jco.ascopubs.org/content/17/3/846.abstract | Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial |
| http://www.nejm.org/doi/full/10.1056/NEJM199808063390601?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=339&volume=339&firstpage=357&firstpage=357 | Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment |
| http://www.nejm.org/doi/full/10.1056/NEJM199612123352401 | Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases |
| http://cigjournals.metapress.com/content/b67871l166135087/fulltext.pdf?page=1 | Treatment of Metastatic ErbB2-positive Breast Cancer: Options After Progression On Trastuzumab |
| http://www.current-oncology.com/index.php/oncology/article/view/230 | Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group |
| http://www.hemonc.theclinics.com/article/S0889-8588(07)00020-2/abstract | Bevacizumab for Advanced Breast Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2807%2960028-2/abstract | 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial |
| http://www.nejm.org/doi/full/10.1056/NEJMoa064320 | Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer |
| http://www.asco.org/ASCOv2/Education+%26+Training/Educational+Book?&vmview=edbk_detail_view&confID=40&abstractID=3 | Management of HER2-Positive Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa053028 | Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMp058315 | Herceptin and the Heart -- A Molecular Modifier of Cardiac Failure |
| http://www.nejm.org/doi/full/10.1056/NEJMoa052306 | Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa052122 | Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer |
| http://jco.ascopubs.org/content/20/3/719.abstract | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJM200103153441101 | Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 |
| http://www.nejm.org/doi/pdf/10.1056/NEJMcpc059030 | Case 35-2005 — A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node |
| http://jco.ascopubs.org/content/14/5/1558.abstract | Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave- Roussy Breast Cancer Group |
| http://www.nejm.org/doi/full/10.1056/NEJM199511303332203 | Reanalysis and Results after 12 Years of Follow-Up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer |
| http://jco.ascopubs.org/content/10/6/976.abstract | Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute |
| http://jnci.oxfordjournals.org/content/103/6/478.abstract | Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS *New* |
| http://www.nejm.org/doi/full/10.1056/NEJMra031301?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=350&volume=350&firstpage=1430&firstpage=1430 | Medical Progress: Ductal Carcinoma in Situ of the Breast |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2899%2905036-9/abstract | Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial |
| http://ex2.excerptamedica.com/CIW-09ecco/index.cfm?fuseaction=CIS2002&hoofdnav=Abstracts&content=abs.details&what=FREE%20TEXT&searchtext=Coombes&topicselected=*&selection=ABSTRACT&qryStartRowDetail=1 | Survival and safety post study treatment completion: an updated analysis of the Intergroup Exemestane Study (IES) - submitted on behalf of the IES Investigators |
| http://cancerres.aacrjournals.org/cgi/content/abstract/69/2_MeetingAbstracts/13 | BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer |
| http://cancerres.aacrjournals.org/cgi/content/abstract/69/24_MeetingAbstracts/12 | Disease Related Outcome with Long Term Follow-up: An Updated Analysis of the Intergroup Exemestane Study (IES) |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2807%2970385-6/abstract | Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial |
| http://www.current-oncology.com/index.php/oncology/article/view/180/153 | Cancer Therapy Disparity: Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada |
| http://journals.lww.com/journalppo/Abstract/2007/05000/Breast_Cancer_Adjuvant_Endocrine_Therapy.3.aspx | Breast Cancer Adjuvant Endocrine Therapy |
| http://jco.ascopubs.org/content/25/5/486.abstract | Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 |
| http://annonc.oxfordjournals.org/content/17/suppl_7/vii10.abstract | Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial |
| http://jama.ama-assn.org/content/295/23/2727.short | Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes |
| http://www.nejm.org/doi/full/10.1056/NEJMoa052258?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=353&volume=353&firstpage=2747&firstpage=2747 | A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer |
| http://jnci.oxfordjournals.org/content/97/17/1262.short | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2805%2967059-6/abstract | Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)66544-0/fulltext | Effects of Chemotherapy and Hormonal Therapy for Early Breast Cancer on Recurrence and 15-year Survival: an overview of the randomised trials |
| http://www.nejm.org/doi/full/10.1056/NEJMoa040331?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=350&volume=350&firstpage=1081&firstpage=1081 | A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer |
| http://www.lancet.com/journals/lancet/article/PIIS0140673604154937/fulltext | HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped |
| http://www.nejm.org/doi/full/10.1056/NEJMoa032312?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=349&volume=349&firstpage=1793&firstpage=1793 | A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer |
| http://theoncologist.alphamedpress.org/content/8/4/335.full | Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2802%2909088-8/abstract | Anastrozole Alone or in Combination with Tamoxifen Versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: first results of the ATAC randomised trial |
| http://jco.ascopubs.org/content/19/10/2596.abstract | Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group |
| http://jnci.oxfordjournals.org/content/93/9/684.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=93&firstpage=684&resourcetype=HWCIT | Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial |
| http://www.nejm.org/doi/full/10.1056/NEJMoa012158?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=346&volume=346&firstpage=1616&firstpage=1616 | Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations |
| http://www.nejm.org/doi/full/10.1056/NEJM199901143400201?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=340&volume=340&firstpage=77&firstpage=77 | Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer |
| http://jco.ascopubs.org/content/early/2011/09/11/JCO.2010.32.6462.short?rss=1 | Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics |
| http://jco.ascopubs.org/content/early/2011/09/11/JCO.2010.33.1298.short?rss=1 | Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial |
| http://www.sciencedirect.com/science/article/pii/S0305737203001415 | Follow-up care of patients treated for breast cancer: a structured review |
| http://jco.ascopubs.org/content/19/6/1865.abstract | 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology |
| http://www.bronchialkarzinom-aktuell.de/fileadmin/media/pdf/lancet.pdf | Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial |
| http://www.nejm.org/doi/full/10.1056/NEJMoa060570 | DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy |
| http://www.nejm.org/doi/full/10.1056/NEJMoa060467 | A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer |
| http://clinicaltrials.gov/ct2/show/NCT00558636?cond | A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60780-0/abstract?rss=yes | Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial |
| http://www.eurekalert.org/pub_releases/2011-09/acor-cca090611.php | Concurrent chemo and radiation therapy improves long-term survival for inoperable stage III lung cancer |
| http://jnci.oxfordjournals.org/content/early/2011/09/06/jnci.djr325.abstract | Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 |
| http://jco.ascopubs.org/content/26/6/863.abstract | Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2 |
| http://jco.ascopubs.org/content/26/1/60.abstract | Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 |
| http://jco.ascopubs.org/content/25/7/760.abstract | Phase II Clinical Trial of Chemotherapy-Naïve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer |
| http://jco.ascopubs.org/content/25/5/587.abstract | Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer |
| http://jco.ascopubs.org/content/early/2011/08/22/JCO.2011.36.4539.abstract | Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses |
| http://jama.ama-assn.org/content/305/22/2335 | Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2811%2970199-1/abstract | Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000—05): an open-label, randomised, phase 3 trial |
| http://jco.ascopubs.org/content/early/2011/03/07/JCO.2010.33.6297.abstract | Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer |
| http://annonc.oxfordjournals.org/content/20/4/674.abstract | A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) |
| http://jco.ascopubs.org/content/25/23/3456.abstract | Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone as Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803 |
| http://jco.ascopubs.org/content/25/16/2198.abstract | Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 |
| http://jco.ascopubs.org/cgi/mjgca?SEARCHID=1&FIRSTPAGE=8664&FIRSTINDEX=0&hits=10&RESULTFORMAT=&gca=jco%3B23%2F34%2F8664 | Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials |
| http://www.nejm.org/doi/full/10.1056/NEJMoa043116 | Capecitabine as Adjuvant Treatment for Stage III Colon Cancer |
| http://jco.ascopubs.org/content/22/16/3408.full | American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer |
| http://jco.ascopubs.org/content/22/16/3395.abstract | Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group |
| http://jco.ascopubs.org/content/22/16/3277.abstract | Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared With Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130 |
| http://www.nejm.org/doi/full/10.1056/NEJMoa032709 | Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer |
| http://jco.ascopubs.org/content/27/31/5124.abstract | Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03 |
| http://jco.ascopubs.org/content/27/31/5115.full | Is Preoperative Chemoradiotherapy Still the Treatment of Choice for Rectal Cancer? |
| http://jco.ascopubs.org/content/24/22/3542.abstract | Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144 |
| http://www.nejm.org/doi/full/10.1056/NEJMoa040694?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=351&volume=351&firstpage=1731&firstpage=1731 | Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60399-1/abstract | Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(11)70102-4/abstract | Intermittent versus continuous oxaliplatin and fl uoropyrimidine combination chemotherapy for fi rst-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2811%2970199-1/abstract | Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial |
| http://jco.ascopubs.org/content/27/34/5727.abstract | Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study |
| http://jco.ascopubs.org/content/26/12/2006.abstract | Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2807%2961087-3/fulltext | Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial |
| http://jco.ascopubs.org/content/25/13/1670.abstract | Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/22/7/1209.abstract | Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment |
| http://www.nature.com/bjc/journal/v90/n6/abs/6601676a.html | Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials |
| http://jco.ascopubs.org/content/22/1/23.abstract | A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/22/2/229.abstract | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study |
| http://jco.ascopubs.org/content/21/11/2059.abstract | Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial |
| http://www.nejm.org/doi/full/10.1056/NEJM200009283431302 | Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673600020341/abstract | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60613-2/abstract | Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial |
| http://jco.ascopubs.org/content/early/2010/10/01/JCO.2009.27.4860 | Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa0805019 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa0804385 | K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer |
| http://jco.ascopubs.org/content/26/10/1626.abstract | Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa071834 | Cetuximab for the Treatment of Colorectal Cancer |
| http://jco.ascopubs.org/content/25/13/1658.abstract | Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa033025 | Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/28/19/3191.full | Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study |
| http://jco.ascopubs.org/content/27/5/663.full.pdf+html | Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/26/12/2013.abstract | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study |
| http://jco.ascopubs.org/content/25/12/1539.abstract | Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 |
| http://jco.ascopubs.org/content/23/16/3706.abstract | Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/23/15/3502.abstract | Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa032691 | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer |
| http://www.biomedcentral.com/1471-2407/11/367 | A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial |
| http://jco.ascopubs.org/content/27/5/672.long | A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa0808268 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer |
| http://jco.ascopubs.org/content/25/29/4557.full | Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study |
| http://www.nejm.org/doi/full/10.1056/NEJMoa073149 | Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer |
| http://jco.ascopubs.org/content/25/22/3205.abstract | Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Cancer Adenocarcinoma: The V-325 Study Group |
| http://jco.ascopubs.org/content/25/22/3217.abstract | Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research |
| http://www.nejm.org/doi/full/10.1056/NEJMoa055531 | Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer |
| http://jco.ascopubs.org/content/24/18/2903.full | Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data |
| http://jco.ascopubs.org/content/22/21/4319.abstract | Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa010187 | Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction |
| http://jco.ascopubs.org/content/18/14/2648.abstract | Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer |
| http://jco.ascopubs.org/content/15/1/261.abstract | Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer |
| http://jama.ama-assn.org/content/299/9/1019.abstract | Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial |
| http://jama.ama-assn.org/content/297/3/267.full | Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial |
| http://www.nejm.org/doi/full/10.1056/NEJMoa032295 | A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer |
| http://www.nejm.org/doi/full/10.1056/NEJMoa1011923 | FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer |
| http://jco.ascopubs.org/content/28/22/3605.abstract?ct | Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 |
| http://jco.ascopubs.org/content/28/22/3617.abstract?ct | Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) |
| http://jco.ascopubs.org/content/27/33/5513.abstract | Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancrea |
| http://jco.ascopubs.org/content/25/18/2607.abstract | |
| http://jco.ascopubs.org/content/25/16/2159.full | |
| http://jco.ascopubs.org/content/25/16/2212.abstract | |
| http://jco.ascopubs.org/content/25/15/1949.full | |
| http://jco.ascopubs.org/content/25/15/1960.abstract | |
| http://l39gg632kcb0ewpfj-sites-default-files.s3.amazonaws.com/follow-up%20guidelines%20nephrectomy.pdf | |
| http://jco.ascopubs.org/content/26/18/2966.full | |
| http://jco.ascopubs.org/content/25/11/1310.abstract | |
| http://jco.ascopubs.org/content/15/2/594.abstract | |
| http://jco.ascopubs.org/content/28/4/531.abstract | |
| http://jco.ascopubs.org/content/28/4/537.abstract | |
| http://jco.ascopubs.org/content/28/4/519.full | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa067749 | |
| http://jco.ascopubs.org/content/22/6/1034.full | |
| http://jco.ascopubs.org/content/25/21/3090.abstract | |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470204503012786/abstract | |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470204503012798/abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJM199707243370406?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=337&volume=337&firstpage=242&firstpage=242 | |
| http://archinte.ama-assn.org/cgi/content/abstract/171/16/1487 | |
| http://dovepress.com/critical-appraisal-of-pazopanib-as-treatment-for-patients-with-advance-peer-reviewed-article-CMAR | |
| http://jco.ascopubs.org/content/28/6/1061.abstract | |
| http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(09)70162-7/fulltext | |
| http://jco.ascopubs.org/content/27/22/3584.full.pdf+html | |
| http://jco.ascopubs.org/content/27/20/3312.full | |
| http://jco.ascopubs.org/content/26/22/3763.full | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673607619047/abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa066838 | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa065044 | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa060655 | |
| http://jco.ascopubs.org/content/24/35/5601.abstract | |
| http://onlinelibrary.wiley.com/doi/10.1002/cncr.11571/abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa003013 | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673601061037/abstract | |
| http://onlinelibrary.wiley.com/doi/10.1002/cncr.23056/abstract | |
| http://www.jurology.com/article/PIIS0022534705678895/abstract | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673698035442/abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJM199804303381804 | |
| http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ArtikelNr=327452&Ausgabe=255521&ProduktNr=231997 | |
| http://jco.ascopubs.org/content/28/11/1850.full.pdf | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa022148 | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140673603135805/abstract | |
| http://jco.ascopubs.org/content/18/17/3068.abstract | |
| http://annonc.oxfordjournals.org/content/11/7/851.full.pdf+html | |
| http://jco.ascopubs.org/content/17/10/3173.abstract | |
| http://journals.lww.com/oncology-times/Fulltext/2011/09100/Prostate_Cancer_Biomarkers__Research_Updates_at.5.aspx | |
| http://onlinelibrary.wiley.com/doi/10.1002/cncr.26437/abstract | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2962344-6/abstract | |
| http://jnci.oxfordjournals.org/content/96/11/879.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=96&firstpage=879&resourcetype=HWCIT | |
| http://jco.ascopubs.org/content/21/23/4277.abstract | |
| http://jnci.oxfordjournals.org/content/95/17/1300.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=95&firstpage=1300&resourcetype=HWCIT | |
| http://jco.ascopubs.org/content/21/17/3335.abstract | |
| http://jnci.oxfordjournals.org/content/95/17/1262.extract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=95&firstpage=1262&resourcetype=HWCIT | |
| http://jnci.oxfordjournals.org/content/94/19/1458.abstract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=94&firstpage=1458&resourcetype=HWCIT | |
| http://jnci.oxfordjournals.org/content/94/19/1422.extract?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=94&firstpage=1422&resourcetype=HWCIT | |
| http://annonc.oxfordjournals.org/content/early/2011/09/07/annonc.mdr380.abstract | |
| http://jco.ascopubs.org/content/25/6/669.abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa041318?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=351&volume=351&firstpage=1513&firstpage=1513 | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa040720?FIRSTINDEX=0&searchid=1&resourcetype=HWCIT&sendit=GO&volume=351&volume=351&firstpage=1502&firstpage=1502 | |
| http://jco.ascopubs.org/content/14/6/1756.abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa1001294 | |
| http://jco.ascopubs.org/content/22/6/1025.abstract | |
| http://jco.ascopubs.org/content/19/1/62.abstract | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa1014618 | |
| http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2961389-X/abstract | |
| http://jco.ascopubs.org/content/25/25/3965.abstract | |
| http://onlinelibrary.wiley.com/doi/10.1002/hed.21848/abstract | |
| http://onlinelibrary.wiley.com/doi/10.1002/hed.21858/abstract | |
| http://www.ascopost.com/articles/september-1-2011/circulating-tumor-cell-assay-shows-potential-for-predicting-prognosis-in-head-and-neck-carcinoma.aspx | |
| http://jco.ascopubs.org/content/early/2011/08/09/JCO.2011.35.7301.short?rss=1 | |
| http://www.oraloncology.com/article/PIIS1368837511007640/abstract?rss=yes | |
| http://www.springerlink.com/content/76g4vtw146638521/ | |
| http://www.nejm.org/doi/full/10.1056/NEJMoa0912217 | |
| http://twitter.com/#!/OncEd | |
| http://www.linkedin.com/company/oncologyeducation-com | |
| http://www.facebook.com/pages/OncologyEducationcom/185611721497922 | |
| http://www.regonline.ca/builder/site/Default.aspx?EventID=954549 | |
| http://www.google.com/calendar/event?eid=YmY4Yjc3aWt1aWFjZDBybHBuY2J1dm50YTggaW5mb0BvbmNvbG9neWVkdWNhdGlvbi5jYQ | |
| http://www.google.com/calendar/event?eid=c2x0cDg2Z3BoY3RzZThkbXBqOTZrbHVhNmMgaW5mb0BvbmNvbG9neWVkdWNhdGlvbi5jYQ | |
| http://www.google.com/calendar/event?eid=OHY4ZmxmaTQ1YjQ0b3E2ZDZyaDZkamVndmMgaW5mb0BvbmNvbG9neWVkdWNhdGlvbi5jYQ | |
| http://www.google.com/calendar/event?eid=cm90Y29ybjhvaG9kMWg1bjRsNTAzcHJxa2cgaW5mb0BvbmNvbG9neWVkdWNhdGlvbi5jYQ | |
| http://www.google.com/calendar/event?eid=cTB0NWFmcGdnanJ0bnZsajgzcGpnYWc1NTggaW5mb0BvbmNvbG9neWVkdWNhdGlvbi5jYQ | |
| http://t.co/Ya7x7gmK | |
| http://twitter.com/OncEd/statuses/124665006674550784 | |
| http://www.facebook.com/twitter | |
| http://t.co/1A1R8ebr | |
| http://twitter.com/OncEd/statuses/124546098802073601 | |
| http://www.facebook.com/twitter | |
| http://t.co/sLpHsBH9 | |
| http://twitter.com/OncEd/statuses/124480115274031104 | |
| http://www.facebook.com/twitter | |
| http://t.co/H3Esk0j9 | |
| http://twitter.com/OncEd/statuses/124479381186945025 | |
| http://www.facebook.com/twitter | |
| http://t.co/drgE47NU | |
| http://twitter.com/OncEd/statuses/124297108466569217 | |
| http://www.facebook.com/twitter | |
| http://www.bigblockstudios.ca | |
| https://www.healthonnet.org/HONcode/Conduct.html?HONConduct215559 | |
| http://www.healthonnet.org/HONcode/Conduct.html | |
| https://www.healthonnet.org/HONcode/Conduct.html?HONConduct215559 |